Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + Dacarbazine in Advanced Metastatic Melanoma
NCT00492297Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sorafenib in melanoma, sponsored by Bayer. Started Apr 2005; status: completed.
02
Drugs
sorafenib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00492297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492297.